Chandan Healthcare Limited (NSE:CHANDAN)
India · Delayed Price · Currency is INR 227.10
-5.40 (-2.32%)
At close: Oct 1, 2026
Chandan Healthcare Revenue
Chandan Healthcare had revenue of 822.64M INR in the quarter ending June 30, 2026, with 31.31% growth. This brings the company's revenue in the last twelve months to 2.94B, up 20.35% year-over-year. In the fiscal year ending March 31, 2026, Chandan Healthcare had annual revenue of 2.76B with 20.11% growth.
Revenue (ttm)
2.94B
Revenue Growth
+20.35%
P/S Ratio
1.89
Revenue / Employee
2.47M
Employees
1,192
Market Cap
5.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.76B | 462.74M | 20.11% |
| Mar 31, 2025 | 2.30B | 534.40M | 30.25% |
| Mar 31, 2024 | 1.77B | 397.91M | 29.07% |
| Mar 31, 2023 | 1.37B | 173.26M | 14.49% |
| Mar 31, 2022 | 1.20B | 324.01M | 37.17% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 839.76M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |